» Articles » PMID: 21577309

Intestinal Pseudo-obstruction in Inactive Systemic Lupus Erythematosus: An Unusual Finding

Overview
Date 2011 May 18
PMID 21577309
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic intestinal pseudo-obstruction (CIP) is an infrequent complication of an active systemic lupus erythematosus (SLE). We illustrate a case of SLE inactive-related CIP. A 51-year old female with inactive SLE (ECLAM score 2) was hospitalized with postprandial fullness, vomiting, abdominal bloating and abdominal pain. She had had no bowel movements for five days. Plain abdominal X-ray revealed multiple fluid levels and dilated small and large bowel loops with air-fluid levels. Intestinal contrast radiology detected dilated loops. CIP was diagnosed. The patient was treated with prokinetics, octreotide, claritromycin, rifaximin, azathioprine and tegaserod without any clinical improvement. Then methylprednisolone (500 mg iv daily) was started. After the first administration, the patient showed peristaltic movements. A bowel movement was reported after the second administration. A plain abdominal X-ray revealed no air-fluid levels. Steroid therapy was slowly reduced with complete resolution of the symptoms. The patient is still in a good clinical condition. SLE-related CIP is generally reported as a complication of an active disease. In our case, CIP was the only clinical demonstration of the SLE.

Citing Articles

Early Intervention and Resolution of Pediatric Intestinal Pseudo-Obstruction in Systemic Lupus Erythematosus: A Pediatric Case Report.

Hsu D, Khalsa U, Hassan M, Sandborg C, Namjoshi S JPGN Rep. 2023; 2(1):e041.

PMID: 37206925 PMC: 10191485. DOI: 10.1097/PG9.0000000000000041.


Lupus intestinal pseudo-obstruction and hydronephrosis: Case report.

Adler B, Timlin H, Birnbaum J Medicine (Baltimore). 2019; 98(28):e16178.

PMID: 31305400 PMC: 6641825. DOI: 10.1097/MD.0000000000016178.


A Case of Dermatomyositis and Anti-EJ Autoantibody with Chronic Intestinal Pseudoobstruction Successfully Treated with Octreotide.

Yamada C, Sato S, Sasaki N, Kurabayashi T, Sasaki S, Koyama Y Case Rep Rheumatol. 2016; 2016:9510316.

PMID: 27885350 PMC: 5112325. DOI: 10.1155/2016/9510316.


Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction.

Ambartsumyan L, Flores A, Nurko S, Rodriguez L Paediatr Drugs. 2016; 18(5):387-92.

PMID: 27520652 DOI: 10.1007/s40272-016-0189-x.


Clinical analysis of 61 systemic lupus erythematosus patients with intestinal pseudo-obstruction and/or ureterohydronephrosis: a retrospective observational study.

Xu N, Zhao J, Liu J, Wu D, Zhao L, Wang Q Medicine (Baltimore). 2015; 94(4):e419.

PMID: 25634172 PMC: 4602957. DOI: 10.1097/MD.0000000000000419.


References
1.
Hallegua D, Wallace D . Gastrointestinal manifestations of systemic lupus erythematosus. Curr Opin Rheumatol. 2000; 12(5):379-85. DOI: 10.1097/00002281-200009000-00005. View

2.
Connor F, Di Lorenzo C . Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology. 2006; 130(2 Suppl 1):S29-36. DOI: 10.1053/j.gastro.2005.06.081. View

3.
Cogliandro R, De Giorgio R, Barbara G, Cogliandro L, Concordia A, Corinaldesi R . Chronic intestinal pseudo-obstruction. Best Pract Res Clin Gastroenterol. 2007; 21(4):657-69. DOI: 10.1016/j.bpg.2007.03.002. View

4.
Moldovan I . Systemic lupus erythematosus: current state of diagnosis and treatment. Compr Ther. 2007; 32(3):158-62. DOI: 10.1007/s12019-006-0006-5. View

5.
Griffiths B, Mosca M, Gordon C . Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19(5):685-708. DOI: 10.1016/j.berh.2005.03.010. View